| 2022-06-06 | Sale | Bristol-Myers Squibb Company BMY | EVP, General Counsel | 65,000 0.003% | $74.89 | $4.87M | -2.93% | |
| 2021-07-30 | Sale | Bristol-Myers Squibb Company BMY | EVP, General Counsel | 58,780 0.0027% | $68.04 | $4M | +0.22% | |
| 2020-08-13 | Sale | Bristol-Myers Squibb Company BMY | EVP, General Counsel | 282,840 0.0125% | $63.24 | $17.89M | +0.39% | |
| 2017-12-04 | Sale | Bristol-Myers Squibb Company BMY | EVP, General Counsel | 313,164 0.0131% | $42.76 | $13.39M | -2.41% | |
| 2017-03-06 | Sale | Bristol-Myers Squibb Company BMY | EVP, General Counsel | 184,810 0.0111% | $57.02 | $10.54M | +6.62% | |
| 2016-05-06 | Sale | Bristol-Myers Squibb Company BMY | EVP, General Counsel | 145,088 0.0086% | $70.39 | $10.21M | -19.37% | |
| 2016-02-17 | Sale | Bristol-Myers Squibb Company BMY | EVP, General Counsel | 20,304 0.0012% | $63.57 | $1.29M | -4.41% | |
| 2015-02-17 | Sale | Bristol-Myers Squibb Company BMY | General Counsel & Secretary | 23,492 0.0014% | $60.38 | $1.42M | +9.23% | |
| 2014-02-14 | Sale | Bristol-Myers Squibb Company BMY | General Counsel & Secretary | 20,980 0.0013% | $54.28 | $1.14M | -4.61% | |
| 2013-02-05 | Sale | Bristol-Myers Squibb Company BMY | General Counsel & Secretary | 33,560 0.0021% | $36.87 | $1.24M | +25.63% |